Kailera Therapeutics, Inc. carries a market capitalization of 2.39B, placing it among publicly traded companies globally.
| Market Cap | 2.39B |
| Enterprise Value | N/A |
Kailera Therapeutics, Inc.'s stock has declined approximately -29% over the past 52 weeks. The 50-day moving average sits at 20.84, while the 200-day moving average is 21.66.
| Beta (5Y) | N/A |
| 52-Week Price Change | -29% |
| 50-Day Moving Average | 20.84 |
| 200-Day Moving Average | 21.66 |
| Average Volume (20 Days) | N/A |